Login / Signup

Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".

Antje BischofNico PapinuttoAnisha KeshavanAnand RajeshGina KirkishXinheng ZhangJacob M MallottCarlo AsteggianoSimone SaccoTristan J GundelChao ZhaoWilliam A SternEduardo CaverzasiYifan ZhouRefujia GomezNicholas R RaganAdam SantanielloAlyssa H ZhuJeremy JuwonoCarolyn J BevanRiley M BoveElizabeth Crabtree-HartmanJeffrey M GelfandDouglas S GoodinJennifer S GravesAri J GreenJorge R OksenbergEmmanuelle WaubantMichael R WilsonScott S Zamvilnull nullBruce Anthony Campbell CreeStephen L HauserRoland G Henry
Published in: Annals of neurology (2022)
Keyphrases
  • spinal cord
  • multiple sclerosis
  • mass spectrometry
  • neuropathic pain
  • spinal cord injury
  • ms ms
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • bone marrow